Accessibility

Myasthenia Gravis News

Doctors are learning more about myasthenia gravis (MG) every day. When news about new treatments and new understanding about MG appears, Myasthenia-Gravis.com will update you on this page.

2020 news

Health Union launches new site for myasthenia gravis

Health Union has launched Navigating Life with Myasthenia Gravis, a new place for people living with MG. The site will build over the coming months to include a community where people can connect to others with MG and find medically accurate information. For now, you can help us build this community by following us on Facebook.

Living with MG can be challenging. It is our goal to help you make your life better by providing relevant and timely health information, and meaningful connections to other people with myasthenia gravis.

Study finds protein that predicts MG severity

A recent study from Japan found that levels of a certain protein in the blood may predict the severity of someone’s myasthenia gravis. The protein is called suPAR, which stands for soluble urokinase plasminogen activator receptor. The study suggests that if people with AChR-positive MG have higher levels of suPAR in their blood they may develop more severe disease. More studies need to be done to confirm these results because this study included such a small number of people.1

COVID-19 may make myasthenia gravis worse

A new study found that being infected with COVID-19 can make the symptoms of myasthenia gravis worse. The virus may cause the disease to progress more quickly and may make people with MG more likely to get to other infections. This is an important finding because people with MG use immunosuppressants to control their symptoms, and these drugs also make them more likely to get to infections.2

MGFA’s 2020 virtual conference available online

Learn more about MG and the latest research into the condition. The Myasthenia Gravis Foundation of America has posted recordings of presentations from its 2020 annual meeting. You must register to listen to the presentations.

By providing your email address, you are agreeing to our privacy policy. We never sell or share your email address.

Written by: Jessica Johns Pool | Last reviewed: August 2020